16th October 2014
« All Articles
The Adis Custom Intelligence Service consists of a flexible portfolio of solutions designed to answer some of the key questions facing the pharmaceutical industry and offers a variety of reports to provide more in-depth analysis in this area. In addition to serving the pharmaceutical industry, Adis Custom Intelligence helps non-pharmaceutical organisations who need to draw on specific industry research on a periodic basis, such as the financial and legal markets who may use it for due diligence and M&A purposes. Adis was bought by Springer in 2011. Sophie Alexander recently interviewed William Stow and Donald Schumacher to find out more about the product.
Access to Jinfo articles and reports is a benefit of a Jinfo Subscription.
Please sign in here so that we can check your access to this item:
If this item has been shared with you by a colleague, please request a MyJinfo account.
Gain access to this article with a Jinfo Subscription. It will help your organisation:
Benefits and Pricing
Submit the Subscription Question form to find out if someone in your organisation already has a subscription or to discuss your questions or requirements.Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
Claire LaybatsHead of Commercial Developmentclaire.firstname.lastname@example.org
About this article
Related Subscription Articles:
Related Blog items:
Back to top ^
Login to MyJinfo if you already have a Jinfo Subscription
"Intelligence systems - intelligence 2020"
In the 10 years plus we've been researching developments in news and current awareness, we've predicted and then seen a significant shift from current awareness to intelligence systems. (October - December 2019).
Research Focus »
... more items ...
Visit the Blog »
... more articles ...
... more reports ...
All Content »
© Jinfo Limited 1997-2019 · Cookies, Privacy, Legal